
Sign up to save your podcasts
Or
This week I talk with Deborah Eastwood of the Royal National Orthopedic Hospital in London, England.
The name Debbie Eastwood is synonymous with excellence in Orthopedics stands as a beacon of inspiration and is one of the most influential women in orthopedic surgery. Her remarkable contributions to pediatric orthopedics have left an indelible mark in the field.
Debbie Eastwood's unwavering dedication was recently honored with the lifetime achievement award from the European pediatric orthopedic society. This prestigious recognition, coupled with her involvement in numerous national and international organizations, and her role as a teacher, is a testament to the clarity of her thought.
We begin reviewing her orthopedic journey and background. She discusses her initial approach to the developmental display of the hip and how she reached her opinions.
We consider why national screening programs do not appear to have been as successful as they should have been.
We talk about historical differences in approaching the treatment of developmental dislocation of the hip on both sides of the Atlantic,
We discuss her recent research looking at length discrepancy after the treatment of hip dysplasia and the reason behind this,
We talk about genetics and the future of research for hip dysplasia, amongst other things.
This week I talk with Deborah Eastwood of the Royal National Orthopedic Hospital in London, England.
The name Debbie Eastwood is synonymous with excellence in Orthopedics stands as a beacon of inspiration and is one of the most influential women in orthopedic surgery. Her remarkable contributions to pediatric orthopedics have left an indelible mark in the field.
Debbie Eastwood's unwavering dedication was recently honored with the lifetime achievement award from the European pediatric orthopedic society. This prestigious recognition, coupled with her involvement in numerous national and international organizations, and her role as a teacher, is a testament to the clarity of her thought.
We begin reviewing her orthopedic journey and background. She discusses her initial approach to the developmental display of the hip and how she reached her opinions.
We consider why national screening programs do not appear to have been as successful as they should have been.
We talk about historical differences in approaching the treatment of developmental dislocation of the hip on both sides of the Atlantic,
We discuss her recent research looking at length discrepancy after the treatment of hip dysplasia and the reason behind this,
We talk about genetics and the future of research for hip dysplasia, amongst other things.